Leon Adams

Associate Professor, MB BS PhD W.Aust., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 9580 Citations
  • 37 h-Index
20052020
If you made any changes in Pure these will be visible here soon.

Personal profile

Funding overview

2012: Curtin University, School of Biomedical Sciences Strategic Project Funding Initiative 2012. $10,000. Gene expression analysis of iron-loaded NASH patients. Graham R, Mamotte C. AI. Adams LA.

2012-14: National Health and Medical Research Council Project Grant 1022134. $481,750. Nutritional determinants of cardiometabolic risk and mental health. Oddy WH, Mori TA, Adams L, Byrne S.

2010-12: National Health and Medical Research Council Project Grant 634445.
$641,125. Risk factors for nonalcoholic fatty liver disease beyond insulin resistance: genetic, developmental and environmental influences. Adams LA, Olynyk JK, Beilin LB, Pennell C, McCaskie P, Oddy W.

2010-14: Canadian Institutes of Health Research Operating Grant 209483.
$939,441. Gene-environment interactions underlying the developmental origins of health and disease.
Lye SJ, Adams LA, Beilin LJ, Briollais L, Matthews SG, Newnham JP, Olynyk JK, Palmer LJ, Pennell CP.

2010-2011: National Heart Foundation of Australia Grant in Aid. G 09P 4265
$129,000. Chronic viral hepatitis associated vascular morbidity and mortality.
Adams LA, Watts G, Jeffrey GP, Preen D, Hung J.

2010: University of Western Australia, Faculty of Medicine, Dentistry and Health Sciences. Small Equipment Grant. $29,810. Fibroscan XL probe. Adams LA.

2009-11: National Health and Medical Research Council Project Grant 527585.
$527,275. Liver fat and lipid transport in the metabolic syndrome.
Watts GF, Barrett HR, Chan DC, Adams LA.

2008-10: Raine Foundation/Department of Health Clinical Research Grant
$ 390,747, “Impact of iron on insulin resistance and liver histology in non-alcoholic Steatohepatitis”. Raine Medical Foundation

2008: Bristol Myers Squibb Pharmaceuticals.
$40,000. Non-invasive fibrosis assessment in chronic hepatitis B infection.

2008: Department of Health, State Health Research Advisory Committee. $10,000, New Independent Researcher Infrastructure Support Award.

2008: Sir Charles Gairdner Hospital Research Development Grant
$10,000, “Validation of Hepascore in Non-alcoholic Fatty Liver Disease”.

2008: Faculty of Medicine, Dentistry & Health Sciences Seeding Research Grant. $10,000. “WA Liver Tissue and Serum Bank.”

Keywords

  • Liver disease

Fingerprint Dive into the research topics where Leon Adams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Liver Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Liver Cirrhosis Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Fatty Liver Medicine & Life Sciences
Non-alcoholic Fatty Liver Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

19 Citations (Scopus)

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Daniels, S. J., Leeming, D. J., Eslam, M., Hashem, A. M., Nielsen, M. J., Krag, A., Karsdal, M. A., Grove, J. I., Neil Guha, I., Kawaguchi, T., Torimura, T., McLeod, D., Akiba, J., Kaye, P., de Boer, B., Aithal, G. P., Adams, L. A. & George, J., 1 Mar 2019, In : Hepatology. 69, 3, p. 1075-1086 12 p.

Research output: Contribution to journalArticle

Fibrosis
Confidence Intervals
Blood Platelets
Biomarkers
Non-alcoholic Fatty Liver Disease
6 Citations (Scopus)

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR

Metwally, M., Bayoumi, A., Romero-Gomez, M., Thabet, K., John, M., Adams, L. A., Huo, X., Aller, R., García-Monzón, C., Teresa Arias-Loste, M., Bugianesi, E., Miele, L., Gallego-Durán, R., Fischer, J., Berg, T., Liddle, C., Qiao, L., George, J. & Eslam, M., 1 Mar 2019, In : Journal of Hepatology. 70, 3, p. 494-500 7 p.

Research output: Contribution to journalArticle

3' Untranslated Regions
MicroRNAs
Liver
Metabolome
Genes

Associations between remnant lipoprotein cholesterol and non-alcoholic fatty liver disease

Ayonrinde, O., Chin, J., Mori, T., Olynyk, J., Adams, L. & Beilin, L., Sep 2019, In : Journal of Gastroenterology and Hepatology. 34, p. 60-61 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

ASSOCIATIONS BETWEEN REMNANT LIPOPROTEIN CHOLESTEROL AND NONALCOHOLIC FATTY LIVER DISEASE IN ADOLESCENTS

Ayonrinde, O. T., Chin, J., Adams, L., Mori, T., Olynyk, J. & Beilin, L., Oct 2019, In : Hepatology.

Research output: Contribution to journalAbstract/Meeting Abstract

Insulin Resistance
HDL Cholesterol
Adiponectin
Leptin
Serum

Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy

Wallace, M. C., Sek, K., Francis, R. J., Samuelson, S., Ferguson, J., Tibballs, J., Asad, A., Preen, D. B., MacQuillan, G., Garas, G., Adams, L. A. & Jeffrey, G. P., 22 Aug 2019, In : Digestive Diseases and Sciences.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Therapeutics
Disease-Free Survival
fluorocholine
Hepatitis C

Projects 2005 2020